Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Björn, Pilebro"'
Publikováno v:
ESC Heart Failure, Vol 8, Iss 1, Pp 745-749 (2021)
Abstract Aims Wild type transthyretin amyloidosis (ATTRwt) has gained interest during recent years due to better diagnostic tools and the emergence of treatment options. Little is known about the prevalence of the disease. We aimed to investigate the
Externí odkaz:
https://doaj.org/article/90716e29511f4d07ada9de8b3efede04
Autor:
Hedvig Paulsson Rokke, Nima Sadat Gousheh, Per Westermark, Ole B. Suhr, Intissar Anan, Elisabet Ihse, Björn Pilebro, Jonas Wixner
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-10 (2020)
Abstract Background The diagnostic accuracy of histopathological detection of transthyretin amyloid (ATTR) by Congo red staining of abdominal fat samples has been questioned since low sensitivity has been reported, especially for patients with ATTR c
Externí odkaz:
https://doaj.org/article/c40549b432104364b8d7c4ba08cf13ff
Autor:
Erica Irene Uneus, Christer Wilhelmsson, David Bäckström, Intissar Anan, Jonas Wixner, Björn Pilebro, Katrine Riklund, Mattias Ögren, Margareta Ögreen, Jan Axelsson, Ole B. Suhr, Torbjörn Sundström
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
IntroductionHereditary transthyretin (ATTRv) amyloidosis caused by the V30M (p. V50M) mutation is a fatal, neuropathic systemic amyloidosis. Liver transplantation has prolonged the survival of patients and central nervous system (CNS) complications,
Externí odkaz:
https://doaj.org/article/4f2230cb46d24ac39ec5c0e1062d9eaf
Autor:
Intissar Anan, Ole B Suhr, Katarzyna Liszewska, Jorge Mejia Baranda, Björn Pilebro, Jonas Wixner, Elisabet Ihse
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0266092 (2022)
BackgroundWe have previously shown that transthyretin (TTR) amyloidosis patients have amyloid fibrils of either of two compositions; type A fibrils consisting of large amounts of C-terminal TTR fragments in addition to full-length TTR, or type B fibr
Externí odkaz:
https://doaj.org/article/19b9341c1bbd41899b9f9234cdf69edf
Autor:
Hendrik J. Harms, Tor Clemmensen, Sara Rosengren, Lars Tolbod, Björn Pilebro, Gerhard Wikström, Sven-Olof Granstam, Tanja Kero, Marcelo Di Carli, Steen Hvitfeldt Poulsen, Jens Sorensen
Publikováno v:
Harms, H J, Clemmensen, T, Rosengren, S, Tolbod, L, Pilebro, B, Wikström, G, Granstam, S-O, Kero, T, Di Carli, M, Poulsen, S H & Sorensen, J 2023, ' Association of Right Ventricular Myocardial Blood Flow With Pulmonary Pressures and Outcome in Cardiac Amyloidosis ', JACC. Cardiovascular imaging . https://doi.org/10.1016/j.jcmg.2023.01.024
BACKGROUND: Cardiac amyloidosis (CA) is a restrictive and infiltrative cardiomyopathy, characterized by increased biventricular filling pressures and low output. Symptoms are predominantly of right heart origin. The role of right ventricular (RV) myo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c443c54c8bf64b2e9dd708b6be14e08c
https://pure.au.dk/portal/da/publications/association-of-right-ventricular-myocardial-blood-flow-with-pulmonarypressures-and-outcome-incardiac-amyloidosis(6633d0ee-867b-49a3-951d-f202357663e6).html
https://pure.au.dk/portal/da/publications/association-of-right-ventricular-myocardial-blood-flow-with-pulmonarypressures-and-outcome-incardiac-amyloidosis(6633d0ee-867b-49a3-951d-f202357663e6).html
Autor:
Ole B. Suhr, Jonas Wixner, Viktor Löfbacka, Intissar Anan, Krister Lindmark, Torbjörn Sundström, Björn Pilebro, Per Lindqvist
Publikováno v:
Clinical Physiology and Functional Imaging. 41:408-416
AIMS/BACKGROUND: Transthyretin amyloid (ATTR) amyloidosis cardiomyopathy is an underdiagnosed, causatively treatable cause of heart failure. The aim of this study was to evaluate the efficacy of electrocardiography (ECG) and echocardiography on patie
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 48:1822-1832
Purpose Hereditary transthyretin-amyloid amyloidosis (ATTRv) is an underdiagnosed condition commonly manifesting as congestive heart failure. Recently, scintigraphy utilizing DPD as a tracer was shown to identify ATTRv and wild-type ATTR cardiomyopat
Publikováno v:
Amyloid. 27:191-199
Background: Hereditary transthyretin amyloid (ATTRv) is a systemic amyloidosis with mainly neurological and cardiac symptoms. The aim of this study was to evaluate the outcome of [18F]Flutemetamol PET/CT-scan of the heart in long-term survivors with
Autor:
Intissar Anan, Ole B. Suhr, Katarzyna Liszewska, Jorge Mejia Baranda, Björn Pilebro, Jonas Wixner, Elisabet Ihse
Background We have previously shown that transthyretin (TTR) amyloidosis patients have amyloid fibrils of either of two compositions; type A fibrils consisting of large amounts of C-terminal TTR fragments in addition to full-length TTR, or type B fib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c552f08a1640ebdd47b9aa2721e0e137
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-193805
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-193805
Autor:
Edward J. Gane, Jörg Täubel, Björn Pilebro, Marianna Fontana, Justin Kao, Michael Maitland, Mark Stroh, Jessica Seitzer, Jonathan Phillips, Kristy Wood, Yuanxin Xu, Carri Boiselle, Adam Amaral, Adam Boyd, Jeffrey Cehelsky, David Gustein, Odelya Pagovich, Laura Sepp-Lorenzino, Liron Walsh, David Lebwohl, Gillmore Julian
Publikováno v:
Journal of Hepatology. 77:S58-S59